Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Privi Speciality Chemicals Acquisition

Privi Speciality Chemicals' NCLT-convened equity shareholder meeting approved the Scheme of Amalgamation of Privi Fine Sciences and Privi Biotechnologies into the company. The special resolution passed with requisite majority, subject to scrutinizer report.

Source

BSE filing, NSE: PRIVISCL. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Privi Speciality Chemicals Ltd: key numbers

Share price
₹3,475.90
Market cap
₹13,578 Cr
Revenue (annual)
₹2,564 Cr
Net profit (annual)
₹327.5 Cr
P/E (TTM)
38.8×Sector 34.1×
Promoter holding
60.60%+0.00% QoQ
FII holding
2.78%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Privi Speciality Chemicals Ltd

All →

Other acquisition announcements

All →